4th Quarter - Report

AMERICAN MEDICAL ASSOCIATION for AMERICAN MEDICAL ASSOCIATION

Firm
Client
Income
—
Expenses
$4,740,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Scope of Practice Veterans Choice Program/community care program transition Tricare access Telehealth

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
RICHARD A DEEM —
MARGARET D GARIKES —
JASON ALAN SCULL —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); U.S. Customs & Border Protection; Agriculture, Dept of (USDA); Labor, Dept of (DOL); Internal Revenue Service (IRS); Bureau of Citizenship & Immigration Services (BCIS); Homeland Security, Dept of (DHS); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); Federal Trade Commission (FTC); Food & Drug Administration (FDA); White House Office; Veterans Affairs, Dept of (VA); U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions H.R. 930, Lymphedema Treatment Act, all provisions S. 497, Lymphedema Treatment Act, all provisions H.R. 6836, CLINICAL TREATMENT Act, all provisions S. 3592, No More Surprise Medical Bills Act of 2018, all provisions H.R. 7122, Shared Accountability for Improved Patient Outcomes Act of 2018, all provisions H.R. 6, SUPPORT for Patients and Communities Act, all provisions S. 3120, HEAL Act of 2018, all provisions H.R.3528 - Every Prescription Conveyed Securely Act, all provisions S. 2460, Every Prescription Conveyed Securely Act, all provisions H.R. 2687, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions S. 1169, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions S. 1016, CONNECT for Health Act of 2017, provisions relating to telehealth Medicare program: Protecting Patients from Surprise Medical Bills Act Medicare program: Protecting Access to Medicare Act (PAMA)/physician office labs Medicare program: Medicare Access and Chip Reauthorization Act (MACRA) implementation Medicare program: Merit-based Incentive Payment System (MIPS) Medicare program: MIPS cost measures Medicare program: MIPS impact on Part B drugs and DME Medicare program: Physician-Focused Payment Model Technical Advisory Committee (PTAC) Medicare program: Diabetes Prevention Program/virtual coverage Medicare program: Evaluation and Management Codes/documentation Medicare program: Medicare physician fee schedule Medicare program: Medicare Advantage (MA) and Part D Medicare program: Quality Payment Program Medicare program: Shared Savings Program Medicare program: Health IT burdens Medicare program: Surprise billing Medicare program: Graduate Medical Education (GME) Medicare program: Alternative Payment Models (APMs) Medicare program: Appropriate Use Criteria Medicare program: Cybersecurity Medicare program: Interoperability Medicare program: Stark/Anti-kickback Medicare program: Privacy Medicare program: Regulatory relief Medicare program: Step therapy Medicare program: Residents/minor procedures Medicare program: Prior authorization and utilization management Medicare program: Medicare for all Medicare program: Open Payments Medicare program: PECOS/Medicare Enrollment/Revocations/Revalidations Medicare program: Pharmacy Benefit Manager (PBM)/drug price transparency Medicare program: Misvalued codes Medicare program: List price for drugs Medicare program: Drug pricing transparency

Contacted: Bureau of Citizenship & Immigration Services (BCIS); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); White House Office; SENATE; Drug Enforcement Administration (DEA); Internal Revenue Service (IRS); U.S. Trade Representative (USTR); Veterans Affairs, Dept of (VA); U.S. Customs & Border Protection; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Federal Trade Commission (FTC)

Bills named: H.R. 930 (115th), H.R. 3528 (115th), S. 1016 (115th), H.R. 7122 (115th), H.R. 2687 (115th), H.R. 6 (115th), S. 3120 (115th), S. 1169 (115th), S. 3592 (115th), S. 2460 (115th), H.R. 6836 (115th), S. 497 (115th)

Tobacco TOB

Tobacco/free trade agreement with Japan

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
DEBRA A COHN —
GEORGE E COX —
RICHARD A DEEM —

Contacted: Office of Natl Drug Control Policy (NDCP); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Customs & Border Protection; Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); U.S. Trade Representative (USTR); Internal Revenue Service (IRS); Bureau of Citizenship & Immigration Services (BCIS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Veterans Affairs, Dept of (VA); Drug Enforcement Administration (DEA); Federal Trade Commission (FTC); Agriculture, Dept of (USDA); White House Office

Immigration IMM

H.R. 7052, No Federal Funds for Public Charge Act of 2018, all provisions S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions H-1B Visas Public Charge Alien minors and unaccompanied alien children Medical/mental health care of migrant children and pregnant women in federal custody

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
JENNIFER THOMPSON BROWN —
GEORGE E COX —
RICHARD A DEEM —
MARGARET D GARIKES —
JASON MARINO —

Contacted: Agriculture, Dept of (USDA); Internal Revenue Service (IRS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Veterans Affairs, Dept of (VA); Bureau of Citizenship & Immigration Services (BCIS); U.S. Customs & Border Protection; Labor, Dept of (DOL); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Bills named: S. 898 (115th), H.R. 7052 (115th)

Labor Issues/Antitrust/Workplace LBR

Competition in health insurance marketplace Aetna/CVS merger Insulin pricing

LobbyistCovered position, as disclosed
TODD ASKEW —
LINDSEY BRILL —
CYNTHIA A BROWN —
GEORGE E COX —
RICHARD A DEEM —
SYLVIA TRUJILLO —
ANDREW WANKUM —

Contacted: Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Health Resources & Services Administration (HRSA); White House Office; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Federal Trade Commission (FTC); Drug Enforcement Administration (DEA); U.S. Trade Representative (USTR); U.S. Customs & Border Protection; Bureau of Citizenship & Immigration Services (BCIS); Internal Revenue Service (IRS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Feminine hygiene products tax/HSA/FSA

LobbyistCovered position, as disclosed
CYNTHIA A BROWN —
JENNIFER THOMPSON BROWN —
GEORGE E COX —

Contacted: Health Resources & Services Administration (HRSA); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); White House Office; Office of Natl Drug Control Policy (NDCP); U.S. Trade Representative (USTR); Federal Trade Commission (FTC); Homeland Security, Dept of (DHS); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Bureau of Citizenship & Immigration Services (BCIS); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); Agriculture, Dept of (USDA); U.S. Customs & Border Protection

Budget/Appropriations BUD

H.R. 695, FY 2019 Department of Defense Appropriations Act, 2018, provisions relating to funding for NIH, National Diabetes Prevention Program, community health centers, National Health Service Corps, and Teaching Health Center Graduate Medical Education programs H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to telehealth FY 2019 Commerce, Justice, Science (CJS), and Related Agencies Appropriations Act, 2019, provisions relating to funding for 2020 census

LobbyistCovered position, as disclosed
TODD ASKEW —
CYNTHIA A BROWN —
DEBRA A COHN —
GEORGE E COX —
RICHARD A DEEM —
JASON MARINO —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); White House Office; Office of Natl Drug Control Policy (NDCP); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS); SENATE; Drug Enforcement Administration (DEA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Customs & Border Protection; Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Bureau of Citizenship & Immigration Services (BCIS); Agriculture, Dept of (USDA)

Bills named: H.R. 1892 (115th), H.R. 695 (115th)

Health Issues HCR

H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions H.R. 6199, Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018, all provisions H.R. 6082, Overdose Prevention and Patient Safety Act, provisions relating to 42 CFR Part 2/Privacy S. 2700, Comprehensive Addiction Resources Emergency Act of 2018, provisions relating to workforce training and funding H.R. 1375, Prescriber Support Act of 2017, all provisions S. 2456, CARA 2.0 Act of 2018, all provisions S. 1803, Marijuana Effective Drug Studies (MEDS) Act of 2017, all provisions H.R. 1318, Preventing Maternal Deaths Act of 2018, all provisions S. 1112, Maternal Health Accountability Act of 2017, all provisions 21st Century Cures Act implementation Gun violence prevention and research Firearm purchase background checks Pharmacy benefits manager (PBM) Drug pricing/shortages/prior authorization burdens Cybersecurity Electronic health records (EHR) certification Software as a medical device (SaMD) Opioid abuse Medical price transparency 42 CFR Part 2/Substance abuse confidentiality regulations Administrative burden and simplification Health Savings Accounts - Prescription requirement for over-the-counter medications In-office compounding Telehealth Family and Medical Leave Act (FMLA)/family relationship Medically underserved population/persons with intellectual and developmental disabilities Buprenorphine/hospital inpatients Dietary Guidelines National Practitioner Data Bank National Biodefense strategy

Contacted: Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Homeland Security, Dept of (DHS); U.S. Customs & Border Protection; Health Resources & Services Administration (HRSA); Bureau of Citizenship & Immigration Services (BCIS); Internal Revenue Service (IRS); U.S. Trade Representative (USTR); Office of Natl Drug Control Policy (NDCP); SENATE; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); White House Office; Drug Enforcement Administration (DEA); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 1375 (115th), S. 2456 (115th), H.R. 1318 (115th), H.R. 6 (115th), S. 2700 (115th), H.R. 6082 (115th), S. 1803 (115th), H.R. 6199 (115th), S. 1112 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.